Finsterer Josef, Gama Marques João
Neurology, Neurology and Neurophysiology Center, Vienna, AUT.
Treatment Resistant Schizophrenia Outpatient Clinic, Júlio de Matos Hospital, São José Local Health Unit, Clinical Academic Center of Lisbon, Lisbon, PRT.
Cureus. 2024 Dec 9;16(12):e75432. doi: 10.7759/cureus.75432. eCollection 2024 Dec.
Primary central nervous system lymphoma (PCNSL) is a diffuse, large B-cell lymphoma affecting the brain, spinal cord, leptomeninges, or eyes. A patient with a recurrence of a previous PCNSL manifesting as an isolated vitreoretinal disease without central nervous system (CNS) involvement and a second cerebral recurrence without vitreoretinal involvement has not yet been reported. The patient is an 86-year-old man with PCNSL of the left cerebellum diagnosed at the age of 82 years and treated with suboccipital trepanation and resection of the lesion followed by chemotherapy. At the age of 84, he suffered a first recurrence, which manifested as vitreoretinal lymphoma on the right and later also on the left eye, without CNS involvement. The recurrence was treated by vitrectomy on both sides. At the age of 86, the patient suffered a second recurrence, which manifested as infratentorial lesions treated by radiotherapy. He was discharged with dexamethasone, entecavir, valacyclovir, amphotericin-B, candesartan, tramadol, trazodone, and pantoprazole. This case demonstrates that PCNSL can recur with isolated secondary ophthalmologic lymphoma and a second time with isolated cerebral lymphoma. Although glucocorticoids, chemotherapy, and radiotherapy can be highly effective, the long-term outcomes of patients with PCNSL are not as favorable.
原发性中枢神经系统淋巴瘤(PCNSL)是一种弥漫性大B细胞淋巴瘤,可累及脑、脊髓、软脑膜或眼睛。此前患有PCNSL的患者复发时表现为孤立性玻璃体视网膜疾病且无中枢神经系统(CNS)受累,随后又出现无玻璃体视网膜受累的第二次脑部复发,这种情况尚未见报道。该患者为一名86岁男性,82岁时被诊断为左小脑PCNSL,接受了枕下开颅和病变切除,随后进行化疗。84岁时,他首次复发,表现为右眼玻璃体视网膜淋巴瘤,随后左眼也出现,无CNS受累。双侧均通过玻璃体切除术治疗复发。86岁时,患者第二次复发,表现为幕下病变,接受了放疗。出院时带药有地塞米松、恩替卡韦、伐昔洛韦、两性霉素B、坎地沙坦、曲马多、曲唑酮和泮托拉唑。该病例表明,PCNSL可复发为孤立性继发性眼部淋巴瘤,也可再次复发为孤立性脑部淋巴瘤。尽管糖皮质激素、化疗和放疗可能非常有效,但PCNSL患者的长期预后并不理想。